Ironwood Pharmaceuticals Inc (IRWD) stock
IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)
Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –
Ironwood Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Ironwood Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2026 was 60.1%. For fiscal 2025 it was 33.3%, against 26.5% the year before. The highest annual figure on record is 61.0% in fiscal 2022.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 33.3% | +6.8 |
| FY2024 | Dec 31, 2024 | 26.5% | +240.0 |
| FY2023 | Dec 31, 2023 | -213.5% | −274.5 |
| FY2022 | Dec 31, 2022 | 61.0% | +4.8 |
| FY2021 | Dec 31, 2021 | 56.1% | +19.4 |
| FY2020 | Dec 31, 2020 | 36.7% | +8.7 |
| FY2019 | Dec 31, 2019 | 28.0% | +71.5 |
| FY2018 | Dec 31, 2018 | -43.5% | −38.3 |
| FY2017 | Dec 31, 2017 | -5.2% | +13.8 |
| FY2016 | Dec 31, 2016 | -18.9% | +49.3 |
| FY2015 | Dec 31, 2015 | -68.3% | +153.3 |
| FY2014 | Dec 31, 2014 | -221.6% | +879.8 |
| FY2013 | Dec 31, 2013 | -1101.4% | −1052.9 |
| FY2012 | Dec 31, 2012 | -48.4% | +52.0 |
| FY2011 | Dec 31, 2011 | -100.4% | +38.1 |
| FY2010 | Dec 31, 2010 | -138.6% | +38.6 |
| FY2009 | Dec 31, 2009 | -177.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 70.2% | +17.0 |
| Q1 FY2026 | Mar 31, 2026 | 68.1% | +138.9 |
| Q4 FY2025 | Dec 31, 2025 | 14.3% | −20.5 |
| Q3 FY2025 | Sep 30, 2025 | 61.8% | +33.9 |
| Q2 FY2025 | Jun 30, 2025 | 53.2% | +26.7 |
| Q1 FY2025 | Mar 31, 2025 | -70.7% | −85.5 |
| Q4 FY2024 | Dec 31, 2024 | 34.8% | +2.8 |
| Q3 FY2024 | Sep 30, 2024 | 28.0% | −7.2 |
| Q2 FY2024 | Jun 30, 2024 | 26.5% | +1035.1 |
| Q1 FY2024 | Mar 31, 2024 | 14.7% | −43.0 |
| Q4 FY2023 | Dec 31, 2023 | 32.0% | −31.8 |
| Q3 FY2023 | Sep 30, 2023 | 35.2% | −27.8 |
| Q2 FY2023 | Jun 30, 2023 | -1008.7% | −1065.9 |
| Q1 FY2023 | Mar 31, 2023 | 57.8% | −1.6 |
| Q4 FY2022 | Dec 31, 2022 | 63.8% | +15.5 |
| Q3 FY2022 | Sep 30, 2022 | 63.0% | +0.2 |
| Q2 FY2022 | Jun 30, 2022 | 57.2% | −5.3 |
| Q1 FY2022 | Mar 31, 2022 | 59.3% | +8.2 |
| Q4 FY2021 | Dec 31, 2021 | 48.3% | +4.3 |
| Q3 FY2021 | Sep 30, 2021 | 62.8% | +18.7 |
| Q2 FY2021 | Jun 30, 2021 | 62.6% | +26.0 |
| Q1 FY2021 | Mar 31, 2021 | 51.1% | +34.6 |
| Q4 FY2020 | Dec 31, 2020 | 44.0% | +4.8 |
| Q3 FY2020 | Sep 30, 2020 | 44.1% | −6.1 |
| Q2 FY2020 | Jun 30, 2020 | 36.6% | +15.5 |
| Q1 FY2020 | Mar 31, 2020 | 16.5% | +41.2 |
| Q4 FY2019 | Dec 31, 2019 | 39.3% | +16.4 |
| Q3 FY2019 | Sep 30, 2019 | 50.2% | +273.4 |
| Q2 FY2019 | Jun 30, 2019 | 21.1% | +39.2 |
| Q1 FY2019 | Mar 31, 2019 | -24.6% | +27.2 |
| Q4 FY2018 | Dec 31, 2018 | 22.8% | −67.2 |
| Q3 FY2018 | Sep 30, 2018 | -223.1% | −200.8 |
| Q2 FY2018 | Jun 30, 2018 | -18.1% | +44.9 |
| Q1 FY2018 | Mar 31, 2018 | -51.9% | +24.2 |
| Q4 FY2017 | Dec 31, 2017 | 90.0% | +97.2 |
| Q3 FY2017 | Sep 30, 2017 | -22.4% | +20.4 |
| Q2 FY2017 | Jun 30, 2017 | -63.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -76.1% | – |
| Q4 FY2016 | Dec 31, 2016 | -7.2% | – |
| Q3 FY2016 | Sep 30, 2016 | -42.8% | – |
See a number that looks wrong?